Quality of life and erectile dysfunction

Urology

Volumn 59, Issue 6, 2002, Pages 803-810

  Althof, Stanley E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1; SILDENAFIL;

CLINICAL RESEARCH; CLINICAL TRIAL; DEPRESSION; DEVICE; DIABETES MELLITUS; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; HEART DISEASE; HUMAN; HYPERTENSION; INSURANCE; KIDNEY FAILURE; MULTIPLE SCLEROSIS; PATIENT; PHYSICIAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PSYCHOMETRY; QUALITY OF LIFE; REVIEW; SEXUAL BEHAVIOR; SPINAL CORD INJURY; VACUUM; WORLD HEALTH ORGANIZATION;

FEMALE; HUMANS; IMPOTENCE; INTERPERSONAL RELATIONS; KIDNEY FAILURE, CHRONIC; MALE; PENILE ERECTION; PERSONAL SATISFACTION; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0036097281     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01606-0     Document Type: Review

References (43)

1. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study
2. The evaluation and management of erectile dysfunction
3. Quality-of-life outcomes in men treated for localized prostate cancer
4. The National Institutes of Health chronic prostatitis symptom index: Development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network
5. Health-related quality of life in older men without prostate cancer
6. How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium
7. Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy
8. Relative importance of sexuality and quality of life in patients with prostatic symptoms
9. BPH and sexuality
10. Prostate and sexuality: An overview
11. Erectile dysfunction in patients with diabetes
12. Quality of life in patients with spinal cord injury receiving Viagra® (sildenafil citrate) for the treatment of erectile dysfunction
13. Effect of Viagra (sildenafil citrate) on quality of life in men with erectile dysfunction and multiple sclerosis
14. Prevalence and determinants of erectile dysfunction in hemodialysis patients
15. The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results of the Massachusetts Male Aging Study
16. The relationship between depression and erectile dysfunction
17. The effect of age, ethnicity and geographical location on impotence and quality of life
18. On life satisfaction in male erectile dysfunction
19. Quality of life assessment in sexual dysfunction trials
20. Erectile problems: The perspective of the female
21. Ready, set, stop: Reflections on assessing quality of life and the WHOQOL-100 (U.S. version) - World Health Organization Quality of Life
22. The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction and their partners. MUSE Study Group
23. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction
24. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction
25. Through the eyes of women: The sexual and psychological responses of women to their partner's treatment with self-injection and external vacuum therapy
26. An international comparison of the reliability and responsiveness of the Duke health profile for measuring health-related quality of life of patients treated with alprostadil for erectile dysfunction
27. Quality of life effects of alprostadil therapy for erectile dysfunction: Results of a trial in Europe and South Africa
28. A double-blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction
29. Intracavernosal therapy for erectile failure - Impact of treatment and reasons for drop-out and dissatisfaction
30. Efficacy results and quality-of-life measures in men receiving sildenafil citrate for the treatment of erectile dysfunction
31. Improvement in emotional well-being and relationship of users of sildenafil citrate
32. Treatment of erectile dysfunction in men with depressive symptoms: Results of a placebo-controlled trial with sildenafil citrate
33. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
34. The measurement of life satisfaction
35. Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids
36. The development of erectile dysfunction in men treated for prostate cancer
37. The epidemiology, anatomy, physiology and treatment of erectile dysfunction in chronic renal failure patients
38. Cross-cultural development of a quality of life measure for men with erectile difficulties
39. Sex and the quality of life in Denmark
40. Clinical trials in sexual dysfunction
41. Patients' choice of treatment in stage D prostate cancer
42. Health-related quality of life in men with erectile dysfunction